Dr. David Kideckel, PhD, MBA, joins as Chief Financial Officer, bringing nearly two decades of life sciences, capital markets and corporate advisory experienceCurrent CFO, Mirza Rahimani, transitions to Vice President of Finance, providing continuity across financial reporting and operationsAppointment strengthens Lobe’s leadership team as the Company advances L-130, its differentiated conjugated psilocin therapeutic being developed at sub-hallucinogenic doses for chronic cluster headache
Post Views: 47



